|
Final Report: Hazard\Risk
Timeline: Day 70
Presentation and discussion of Hazard\Risk findings
Cost estimates and findings from all review groups are presented and integrated in a final assessment. A briefing paper is outlined, detailing the findings and the management options.
Description of Finalization Meetings; Input From Risk/Benefit Analysis
Final reports of hazard, risk, engineering, and benefits (maybe links to above) are discussed and integrated.
The risk/benefit analysis covers the market context (how it will be used, cost advantage, efficacy relative to other products, scope and safety), possible products for which the new product could substitute,
and any benefits. In the PMN95 1601 example is it safer, more effective, or faster etc. However, PMN95 1601 is not for a commercial product: it is a test to determine if the idea is feasible. In this case, information is considered the benefit. The test is seen as advancing the science of bioremediation by providing information which could lead to safer, faster, or cheaper remediation procedures. Nevertheless, possible substitutions were considered as if a commercial product could develop from the test. These included new bioremediation methods and new monitoring methods. These findings will affect the selection of management options. Option discussion and report integration is completed during days 70-78.
|
